Trybello has published a guide addressing hair loss after Accutane, explaining the recognized mechanism behind the condition and outlining a general recovery timeline for those affected.
-- Hair care brand Trybello has published a guide addressing hair loss after Accutane (isotretinoin), a topic the company believes is under-discussed compared with the medication's more commonly cited side effects. The guide explains the mechanism behind this type of hair loss and outlines a general recovery timeline for those affected.
More information is available at https://trybello.com/blogs/news/hair-loss-after-accutane-causes-timeline-treatment
The guide comes following data from a retrospective review published in the International Journal of Trichology by researchers at the University of California (UCLA), where reported rates of hair loss following isotretinoin treatment range from roughly 0.28 percent to 12 percent across existing studies, making it an uncommon but recognized side effect rather than a frequent one. Among patients in the UCLA study who did experience hair loss while on isotretinoin, the condition was associated with older age, higher cumulative dosage, and longer treatment duration, though the researchers noted the exact biological mechanism connecting isotretinoin to hair loss remains unclear.
The most common form of hair loss linked to isotretinoin is telogen effluvium, a temporary, diffuse shedding pattern triggered when a physiological stressor pushes large numbers of hair follicles into a resting phase at once. This is in part due to isotretinoin's effect on the sebaceous glands surrounding hair follicles, though researchers note the precise mechanism linking the medication to hair loss is not yet fully established.
Trybello's guide outlines a general timeline in which shedding typically becomes noticeable two to four months after starting treatment, with early signs of regrowth appearing three to four months after the medication is stopped. Most cases resolve substantially within 10 to 16 months, though recovery may look different for individuals who already had underlying pattern hair loss before starting Accutane.
The guide recommends that anyone experiencing significant shedding discuss dose adjustment or discontinuation with a dermatologist rather than making that decision independently, since isotretinoin dosing also affects acne treatment progress.
Trybello takes time to distinguish isotretinoin-related shedding from pattern hair loss, noting the two can occur together in some patients. Telogen effluvium typically presents as diffuse thinning that resolves once the trigger is removed, while pattern hair loss develops gradually, has a genetic component, and does not resolve on its own.
The full guide is available at https://trybello.com/
Contact Info:
Name: TryBello
Email: Send Email
Organization: Trybello LLC
Address: 40 SW 13th St Ste 902, Miami, Florida 33130, United States
Website: https://trybello.com/
Source: PressCable
Release ID: 89206321
Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.
